title: How Genentech Novartis stifled a promising drug: biotech firm tried to pursue a peanut allergy inject, but contract got in way; Zach avoids a "kiss of death".
authors.forename: David P
authors.initials: DP
authors.lastname: Hamilton
mesh_terms: D018926:Anti-Allergic Agents; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D035843:Biomedical Research; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D032982:Contracts / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D015507:Drugs, Investigational / Q000627:therapeutic use; D004465:Economic Competition; D006801:Humans; D021183:Peanut Hypersensitivity / Q000188:drug therapy
chemical_list: D018926:Anti-Allergic Agents; D000911:Antibodies, Monoclonal; D015507:Drugs, Investigational